CVS Health (CVS) Tops Q4 EPS by 7c, Revenues Beat
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $88.84 -1.58%
EPS Growth %: +2.5%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +2.5%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q4 EPS of $1.99, $0.07 better than the analyst estimate of $1.92. Revenue for the quarter came in at $83.85 billion versus the consensus estimate of $76.33 billion.
GUIDANCE:
CVS Health sees FY2023 EPS of $8.70-$8.90, versus the consensus of $8.86.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS cuts KOSPI target by nearly 10% to reflect higher rates
- Aetna expands bundled cancer prior authorizations for Medicaid members
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
